LATEST
Thu, Oct 29, 2026
Loading weather...
Markets

Lab Rats series: Unlocking the kidney for therapy with Helex

Hyderabad-based Helex Inc is working on a first-in-class mechanism to deliver gene editing drugs safely into the kidneys...

Lab Rats series: Unlocking the kidney for therapy with Helex
Source: Mint - Companies

Hyderabad-based Helex Inc is working on a first-in-class mechanism to deliver gene editing drugs safely into the kidneys—a massive medical challenge currently. They not only want to do it first, but also develop it to be affordable for most Indians. 

SOURCE: Mint - Companies
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion

Read More from Markets

Taiwan Stock Market May See Continued Strength On Thursday

(RTTNews) - The Taiwan stock market has finished higher in two straight sessions...

Read Article »

Alkami Technology, Inc. Announces Third Quarter 2026 Financial Results

Alkami Technology, Inc. reported its financial results for the third quarter end...

Read Article »

NeoGenomics, Inc. Reports Third Quarter 2026 Total Revenue of $209 million

NeoGenomics, Inc. reported its financial results for the third quarter ended Sep...

Read Article »
Return to Front Page

5 minutes. The news that matters.

Get the most important stories of the day, without having to browse hundreds of articles.